Northampton outcome for first and second line chemotherapy in non-small cell lung cancer: 5 years data

AIM OF THE STUDY: There is a definite improvement of progression-free survival as well as overall survival in treating patients with non-small cell lung cancer (NSCLC) with second line chemotherapy. We reviewed the use of chemotherapy in the first and second line setting at Northampton Oncology Cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldeeb, Hany, Reza, Shariar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687455/
https://www.ncbi.nlm.nih.gov/pubmed/23788921
http://dx.doi.org/10.5114/wo.2012.31772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687455/
https://www.ncbi.nlm.nih.gov/pubmed/23788921
http://dx.doi.org/10.5114/wo.2012.31772

Ejemplares similares